Healthtech Startups

StataDx is developing a point-of-care diagnostic platform for neurology that measures multiple blood biomarkers (such as Neurofilament-light, pTau-217, GFAP, S100b, and UCH-L1) from a fingerprick whole blood sample. The system uses multiplexed cartridges with mobile and cloud connectivity for biomarker-guided disease management in clinics or at patients' homes.

1 investor

StatDoctor builds technology for healthcare workforce management, using AI-powered credentialling and automation to reduce administrative burden and improve operational efficiency for clinical teams.

1 investor

Statpoint Medical develops software solutions for healthcare providers and care management, enabling better clinical outcomes and operational efficiency in medical settings.

1 investor

Status Health offers at-home lab tests measuring over 300 biomarkers to identify chemical exposure from everyday sources like water, cosmetics, and household products. The company provides personalized digital reports with actionable recommendations to reduce exposure.

1 investor

Stayble Therapeutics is a clinical-stage pharmaceutical company developing an injection-based treatment for disc herniation. The company is currently conducting phase 1b clinical trials for its therapeutic candidate.

1 investor

StaySafe provides lone worker safety software and monitoring services that protect employees working in isolated conditions through mobile apps, GPS tracking, panic buttons, and 24/7 monitoring hubs. The platform serves organizations managing frontline workers, contractors, and field teams across health & safety, emergency response, and crisis management.

1 investor

Steadiwear makes the Steadi-3 Plus, a battery-free anti-tremor glove that uses a magnetic vibration absorber to reduce hand tremors in real time. The FDA-registered Class I device is aimed at people with conditions like Essential Tremor to help with daily tasks such as writing, eating, and cooking.

1 investor

Steadywell provides AI-powered proactive care management software designed for health systems and clinicians to engage patients, conduct advance care planning, and optimize care coordination. The platform uses AI voice agents and workflow automation to help clinicians serve more patients while improving clinical outcomes and patient satisfaction.

1 investor

Steel Therapeutics is a pharmaceutical company that develops a pipeline of drug candidates and manages the associated regulatory, clinical, and product delivery work. It draws on pharmacy compounding and clinical trial expertise to bring medications to market.

1 investor

SteelSky Ventures is a venture fund investing in AI-driven healthcare companies, with a thematic focus on women's health, digital health, and health equity. It backs startups across telemedicine, maternal health, fertility, and chronic care, and reports a portfolio serving over 45 million people globally.

1 investor

Stel provides technology that connects health monitoring devices to electronic health records, transmitting patient vitals without requiring complex setup. It serves health systems and digital health organizations across settings from wellness to hospital-at-home care.

1 investor

Stellation Care provides an analytics platform that uses AI and nationwide Medicare and Medicaid claims data to score provider performance by patient phenotype, helping health plans build and optimize networks and match patients to higher-performing providers. It serves health plans, provider groups, and risk-bearing entities operating in value-based care, offering scorecards, benchmarking, and workflow automation for network design and provider engagement.

1 investor

The Stellenbosch Academy of Sport is a training facility located in South Africa that provides preparation and training services for athletes, featuring both outdoor and indoor sports infrastructure.

1 investor

StemBioSys develops cell culture technology, including the patented CELLvo Matrix that replicates the body's physiological microenvironment to expand mesenchymal stem cells and specialty cells while preserving their stem-like properties. It supplies cells and cell expansion tools for stem cell research and regenerative medicine applications.

1 investor

StemInov is a biotech developing WhartSep, an off-the-shelf stem cell therapy derived from umbilical cord (Wharton's jelly) cells with three complementary actions to treat severe pneumonia and sepsis. The company targets immune disorders and tissue repair as unmet medical needs.

1 investor

Stemline is an oncology-focused pharmaceutical company developing and commercializing cancer therapies, including ELZONRIS (tagraxofusp-erzs) for blastic plasmacytoid dendritic cell neoplasm and ORSERDU (elacestrant) for ER-positive, HER2-negative, ESR-1 mutated advanced or metastatic breast cancer. It is part of the Menarini Group, an international pharmaceutical and diagnostics company.

1 investor

Stemmatters is a Contract Development and Manufacturing Organisation (CDMO) focused on regenerative medicine, providing product and process development plus cGMP production and clinical translation of medicinal products. It supports customers with CMC activities, regulatory dossier preparation, and clinical batch release for investigational and advanced therapy medicinal products.

1 investor

Stem Pharm develops therapeutics using stem cell technology for disease treatment and drug discovery. The company serves pharmaceutical and biotech partners seeking advanced cell-based approaches to translational drug development.

1 investor

StemSight develops stem cell-based therapies to restore sight, focusing on treatments for corneal conditions such as limbal stem cell deficiency using pluripotent stem cells. The company, spun out of the Skottman Lab's Eye Regeneration Group, targets patients with untreatable eye diseases in collaboration with cornea clinicians.

1 investor

STENTiT is a Dutch medtech company developing the Resorbable Fibrillated Scaffold (RFS), a device designed to trigger natural healing and reconstruct arteries for treating vascular conditions. The technology initially targets below-the-knee chronic limb threatening ischemia and has broader applications across endovascular treatments.

1 investor

Stereotaxis develops robotic systems for interventional medicine, focused on endovascular and cardiac procedures such as cardiac ablation. Its technology serves physicians and hospitals performing minimally invasive interventional treatments.

1 investor

Sterilex develops sanitation, disinfection, and microbial control products for use in food processing facilities, water systems, and animal environments.

1 investor

Stethy offers a platform with pre-built, validated AI workflow templates that healthcare and life-science organizations deploy without code to automate clinical processes such as documentation, pharmacovigilance, and compliance checks. Its models are fine-tuned for life-science data and include safety guardrails and proprietary adverse event detection to meet regulatory standards.

1 investor

Stiefel is a biopharmaceutical company that discovers, develops and delivers medicines and vaccines. Its R&D focuses on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases.

1 investor